Hutchison MediPharma and Eli Lilly Sign New Discovery Deal
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Shanghai-headquartered Hutchison MediPharma signed a new partnership agreement with Eli Lilly on drug discovery and development, according to MediPharma's chief executive officer